The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway
Open accessAbstract
Ischemia/reperfusion (I/R) injury is a life-threatening vascular emergency following myocardial infarction. Our previous study showed cardioprotective effects of metformin against myocardial I/R injury. In this study, we further examined the involvement of AMPK mediated activation of NLRP3 inflammasome in this cardioprotective effect of metformin. Myocardial I/R injury was simulated in a rat heart Langendorff model and neonatal rat ventricle myocytes (NRVMs) were subjected to hypoxi/reoxygenation (H/R) to establish an in vitro model. Outcome measures included myocardial infarct size, hemodynamic monitoring, myocardial tissue injury, myocardial apoptotic index and the inflammatory response. myocardial infarct size and cardiac enzyme activities. First, we found that metformin postconditioning can not only significantly alleviated myocardial infarct size, attenuated cell apoptosis, and inhibited myocardial fibrosis. Furthermore, metformin activated phosphorylated AMPK, decreased pro-inflammatory cytokines, TNF-α, IL-6 and IL-1β, and decreased NLRP3 inflammasome activation. In isolated NRVMs metformin increased cellular viability, decreased LDH activity and inhibited cellular apoptosis and inflammation. Importantly, inhibition of AMPK phosphorylation by Compound C (CC) resulted in decreased survival of cardiomyocytes mainly by inducing the release of inflammatory cytokines and increasing NLRP3 inflammasome activation. Finally, in vitro studies revealed that the NLRP3 activator nigericin abolished the anti-inflammatory effects of metformin in NRVMs, but it had little effect on AMPK phosphorylation. Collectively, our study confirmed that metformin exerts cardioprotective effects by regulating myocardial I/R injury-induced inflammatory response, which was largely dependent on the enhancement of the AMPK pathway, thereby suppressing NLRP3 inflammasome activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yue, R., Lu, S., Luo, Y., Wang, T., Liang, H., Jing, Z., Liu, J., & Hu, H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116631 · Cited by 81
Self-citationRetractedThe ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Pyroptosis versus necroptosis: similarities, differences, and crosstalk
Frank, D., & Vince, J. E. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0212-6 · Cited by 1,062
Tamis-Holland, J. E., Jneid, H., Reynolds, H. R., Agewall, S., Brilakis, E. S., Brown, T. M., Lerman, A., Cushman, M., Kumbhani, D. J., Arslanian-Engoren, C., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000670 · Cited by 994
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
Yao, C., Veleva, T., Scott, L., Cao, S., Li, L., Chen, G., Jeyabal, P., Pan, X., Alsina, K. M., Abu-Taha, I., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035202 · Cited by 653
Self-citationMetformin: clinical use in type 2 diabetes
Sanchez-Rangel, E., & Inzucchi, S. E. (2017) · Diabetologia · doi:10.1007/s00125-017-4336-x · Cited by 595
Calvert, J. W., Gundewar, S., Jha, S., Greer, J. J. M., Bestermann, W. H., Tian, R., & Lefer, D. J. (2008) · Diabetes · doi:10.2337/db07-1098 · Cited by 422
Neri, M., Riezzo, I., Pascale, N., Pomara, C., & Turillazzi, E. (2017) · Mediators of Inflammation · doi:10.1155/2017/7018393 · Cited by 379
Zhou, H., Zhang, Y., Hu, S., Shi, C., Zhu, P., Ma, Q., Jin, Q., Cao, F., Tian, F., & Chen, Y. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12413 · Cited by 378
Jia, Y., Cui, R., Wang, C., Feng, Y., Li, Z., Tong, Y., Qu, K., Liu, C., & Zhang, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101534 · Cited by 331
Self-citationRedox regulation in metabolic programming and inflammation
Griffiths, H. R., Gao, D., & Pararasa, C. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.023 · Cited by 285
Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases
Liu, D., Zeng, X., Li, X., Mehta, J. L., & Wang, X. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-017-0663-9 · Cited by 258
Inflammasomes in Tissue Damages and Immune Disorders After Trauma
Bortolotti, P., Faure, E., & Kipnis, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01900 · Cited by 257
NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
Luo, B., Huang, F., Liu, Y., Liang, Y., Wei, Z., Ke, H., Zeng, Z., Huang, W., & He, Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00519 · Cited by 213
Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming
Green, J. P., Yu, S., Martín-Sánchez, F., Pelegrin, P., Lopez-Castejon, G., Lawrence, C. B., & Brough, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812744115 · Cited by 189
Liu, H., Wu, X., Luo, J., Zhao, L., Li, X., Guo, H., Bai, H., Cui, W., Guo, W., Feng, D., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113302 · Cited by 174
Li, R.-L., Wu, S.-S., Wu, Y., Wang, X.-X., Chen, H.-Y., Xin, J.-J., Li, H., Lan, J., Xue, K.-Y., Li, X., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.07.250 · Cited by 161
The role of AMPK in cardiomyocyte health and survival
Bairwa, S. C., Parajuli, N., & Dyck, J. R. B. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.001 · Cited by 148
Kosuru, R., Kandula, V., Rai, U., Prakash, S., Xia, Z., & Singh, S. K. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6780-3 · Cited by 130
Ashabi, G., Khodagholi, F., Khalaj, L., Goudarzvand, M., & Nasiri, M. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-013-9475-2 · Cited by 123
Liu, Z., Chen, J., Huang, H., Kuznicki, M. L., Zheng, S., Sun, W., Quan, N., Wang, L., Yang, H. M., Guo, H.-M., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.022 · Cited by 114
The beneficial roles of metformin on the brain with cerebral ischaemia/reperfusion injury
Leech, T., Chattipakorn, N., & Chattipakorn, S. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104261 · Cited by 114
Zhang, J., Wang, C., Yu, S., Luo, Z., Chen, Y., Liu, Q., Hua, F., Xu, G., & Yu, P. (2014) · Scientific Reports · doi:10.1038/srep07317 · Cited by 88
Self-citationWorldwide disparities in cardiovascular disease: Challenges and solutions
Okwuosa, I. S., Lewsey, S. C., Adesiyun, T. A., Blumenthal, R. S., & Yancy, C. W. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.172 · Cited by 87
Antidiabetic Drug Metformin Suppresses Endotoxin-Induced Uveitis in Rats
Kalariya, N. M., Shoeb, M., Ansari, N. H., Sk, S., & Ramana, K. V. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9432 · Cited by 76
Saber, S., & El-Kader, E. M. A. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00730-6 · Cited by 76
Zhang, Y. W., Liu, X., Zhang, L., Li, X., Zhou, Z., Jiao, L., Shao, Y., Li, M., Leng, B., Zhou, Y., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.001 · Cited by 75
Self-citationKim, E., Lee, S., Lee, S.-Y., Kim, J. K., Jhun, J. Y., Na, H. S., Kim, S. Y., Choi, J. Y., Yang, C. W., Park, S., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.245 · Cited by 69
Potential Roles of Humanin on Apoptosis in the Heart
Charununtakorn, S. T., Shinlapawittayatorn, K., Chattipakorn, S. C., & Chattipakorn, N. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12168 · Cited by 68
Role of Caspase 1 in Ischemia/Reperfusion Injury of the Myocardium
Rauf, A., Shah, M., Yellon, D. M., & Davidson, S. M. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000694 · Cited by 60
Sposito, A. C., Berwanger, O. B., de Carvalho, L. S. F., & Saraiva, J. F. K. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0825-1 · Cited by 51
AMP-activated protein kinase protects against necroptosis via regulation of Keap1-PGAM5 complex
Wang, Y.-S., Yu, P., Wang, Y., Zhang, J., Hang, W., Yin, Z.-X., Liu, G., Chen, J., Werle, K. D., Quan, C., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.036 · Cited by 50
Self-citationWang, Z., Liu, X., Wang, M., Jiang, G., Qiu, T., Chen, Z.-Y., & Wang, L. (2015) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020150090000006 · Cited by 40
Self-citationLee, S.-Y., Ku, H.-C., Kuo, Y., Chiu, H.-L., & Su, M. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0125-3 · Cited by 32
Rameshrad, M., Soraya, H., Maleki‐Dizaji, N., Vaez, H., & Garjani, A. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4821 · Cited by 25
New concepts in the pathophysiology of acute myocardial infarction
Pepine, C. J. (1989) · The American Journal of Cardiology · doi:10.1016/s0002-9149(89)80002-5 · Cited by 21
Jo, W., Kang, K., Chae, S., & Son, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041489 · Cited by 16
Gong, X., Duan, R., Ao, J.-E., Ai, Q., Ge, P., LIN, L., & Zhang, L. R. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4206 · Cited by 10
AMP-activated kinase “Keaps” ischemia/reperfusion-induced necroptosis under control
Kanugula, A. K., & Thodeti, C. K. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.053 · Cited by 7
Cited by
Regulated cell death in myocardial ischemia–reperfusion injury
Xiang, Q., Yi, X., Zhu, X.-H., Wei, X., & Jiang, D.-S. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2023.10.010 · Cited by 448
Wang, Z., Yao, M., Jiang, L., Wang, L., Yang, Y., Wang, Q., Qian, X., Zhao, Y., & Qian, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113572 · Cited by 286
Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment
Xiong, P., Zhang, F., Liu, F., Zhao, J., Huang, X., Luo, D., & Guo, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114545 · Cited by 59
Metadata
- Authors
- Zhang, J., Huang, L., Shi, X., Yang, L., Hua, F., Ma, J., Zhu, W., Liu, X., Xuan, R., Shen, Y., Liu, J., Lai, X., & Yu, P.
- Venue
- Aging
- Publisher
- Impact Journals, LLC
- Published
- 2020-11-24
- Volume
- 12
- Issue
- 23
- Pages
- 24270-24287
- ISSN
- 1945-4589 (ISSN-L)
- OpenAlex
- W3110200930
- Cited by
- 268
- References
- 40
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.